COVID-19 & CancerFreeGuest Editorial Cancer care continues during COVID-19 pandemic—with new tools and old challenges April 17, 2020Vol.46 No.16By Ted Okon
COVID-19 & CancerFreeGuest Editorial Amid COVID-19 pandemic, cancer community responds to fill data gap April 17, 2020Vol.46 No.16By Richard L. Schilsky
COVID-19 & CancerFree American Cancer Society announces a wave of furloughs and layoffs as COVID-19 constricts fundraising April 17, 2020Vol.46 No.16By Alexandria Carolan
COVID-19 & CancerFree As treatments get cancelled because of COVID-19, patients worry about adequacy of care April 17, 2020Vol.46 No.16By Alexandria Carolan
COVID-19 & CancerFree Doroshow: NCI to accrue patients for COVID-19 longitudinal cohortOngoing trials see significant decrease in accrual April 17, 2020Vol.46 No.16By Matthew Bin Han Ong
COVID-19 & CancerFree Lowy: “Our patients are counting on us, and we must not let them down”NCI Frederick lab takes aim at Covid-19 April 17, 2020Vol.46 No.16By Matthew Bin Han Ong
COVID-19 & CancerFreeNCI Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response April 14, 2020Vol.46 No.16By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree A view from the plateau: As Italy’s cases drop, oncologists plan post-COVID-19 agenda April 10, 2020Vol.46 No.15By Alexandria Carolan
COVID-19 & CancerFree NCI to distribute IL-6 inhibitor for cancer patients with COVID-19 lung inflammation April 10, 2020Vol.46 No.15By Matthew Bin Han Ong
COVID-19 & CancerFreeGuest Editorial Chernobyl doctor’s view of COVID-19: Trump threatens 267 years of progress in biomedical research April 10, 2020Vol.46 No.15By Robert Peter Gale
